National Cancer Institute; Amended Notice of Meeting, 9231-9232 [2010-4184]

Download as PDF Federal Register / Vol. 75, No. 39 / Monday, March 1, 2010 / Notices amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Traumatic Brain Injury and Stroke Intervention. Date: March 10–11, 2010. Time: 11 a.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Virtual Meeting) Contact Person: Kevin Walton, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD 20892, 301–435– 1785, kevin.walton@nih.hhs.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: February 23, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health mstockstill on DSKH9S0YB1PROD with NOTICES National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, 16:46 Feb 26, 2010 Jkt 220001 Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Noninvasive Imaging of Beta Cells. Date: March 24, 2010. Time: 3 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Paul A. Rushing, PhD, Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 747, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–8895, rushingp@extra.niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: February 23, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–4181 Filed 2–26–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings [FR Doc. 2010–4178 Filed 2–26–10; 8:45 am] VerDate Nov<24>2008 and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Metabolic Dysfunction Collaborative Interdisciplinary Science. Date: March 24, 2010. Time: 3 p.m. to 4 p.m. PO 00000 Frm 00083 Fmt 4703 Sfmt 4703 9231 Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892. (Telephone Conference Call) Contact Person: Carol J. Goter-Robinson, PhD, Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 748, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–7791, goterrobinsonc@extra.niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; CAMUS Trial. Date: April 2, 2010. Time: 10 a.m. to 1 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Carol J. Goter-Robinson, PhD, Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes Of Health, Room 748, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–7791, goterrobinsonc@extra.niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; ANCA Glomerulonephritis. Date: April 9, 2010. Time: 9 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Carol J. Goter-Robinson, PhD, Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes Of Health, Room 748, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–7791, goterrobinsonc@extra.niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: February 23, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–4183 Filed 2–26–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, E:\FR\FM\01MRN1.SGM 01MRN1 9232 Federal Register / Vol. 75, No. 39 / Monday, March 1, 2010 / Notices the U.S. population. ODS was established in the Office of the Director, NIH, in 1995 as a major provision of the Dietary Supplement Health and Education Act of 1994 (DSHEA). March 10, 2010, 8 a.m. to March 11, 2010, 6 p.m., Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814 which was published in the Federal Register on February 1, 2010, 75 FR 5093. This FRN amends the dates of the meeting to May 10–11, 2010. The meeting is closed to the public. Dated: February 22, 2010. Paul M. Coates, Director, Office of Dietary Supplements, Office of the Director, National Institutes of Health. Dated: February 24, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–4180 Filed 2–26–10; 8:45 am] BILLING CODE 4140–01–P [FR Doc. 2010–4184 Filed 2–26–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration National Institutes of Health Measuring Progress on Food Safety: Current Status and Future Directions; Public Workshop [Docket No. FDA–2010–N–0104] Office of Dietary Supplements (ODS) 2010–2014 Strategic Plan Notice of availability of the ODS Strategic Plan for 2010–2014. ACTION: The Office of Dietary Supplements (ODS) at the National Institutes of Health (NIH) has completed a strategic planning process resulting in the development of the ODS Strategic Plan for 2010–2014, entitled Strengthening Knowledge and Understanding of Dietary Supplements. The strategic plan is available in pdf format on the ODS Web site: https:// ods.od.nih.gov/pubs/strategicplan/ StrategicPlan2010-2014.pdf. The ODS strategic plan was developed after more than a year’s worth of reflection on its programs, activities, and accomplishments, as well as anticipated challenges for the future. It was also shaped by the thoughtful input, comments, and advice received from ODS stakeholder communities throughout the federal government, academia, the dietary supplement industry, consumer advocacy and education groups, and interested consumers. FOR FURTHER INFORMATION CONTACT: Office of Dietary Supplements, National Institutes of Health, 6100 Executive Boulevard, Room 3B01, Bethesda, MD 20892–7517, E-mail: ODS@nih.gov. SUPPLEMENTARY INFORMATION: mstockstill on DSKH9S0YB1PROD with NOTICES SUMMARY: Background The mission of the Office of Dietary Supplements (ODS) is to strengthen knowledge and understanding of dietary supplements by evaluating scientific information, stimulating and supporting research, disseminating research results, and educating the public to foster an enhanced quality of life and health for VerDate Nov<24>2008 16:46 Feb 26, 2010 Jkt 220001 AGENCY: Food and Drug Administration, HHS. ACTION: Notice of public workshop. The Food and Drug Administration (FDA) is announcing a public workshop entitled Measuring Progress on Food Safety: Current Status and Future Directions. The purpose of the public workshop is to inform the public about current and potential measurements for assessing progress in food safety and associated methodological issues and to discuss potential improvements. Date and Time: The public workshop will be held on March 30, 2010, from 9 a.m. to 5 p.m. Location: The public workshop will be held in the Regency A Ballroom of the Hyatt Regency Washington, 400 New Jersey Ave., NW., Washington, DC 20001, 202–737–1234, FAX: 202–737– 5773. Contact Person: For registration information and general questions regarding the workshop, contact Juanita Yates, Center for Food Safety and Applied Nutrition (HFS–009), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740, 301– 436–1731, e-mail: juanita.yates@fda.hhs.gov. Registration: There is no registration fee. However, due to limited seating, we encourage all persons who wish to attend the workshop to register in advance. Attendees may register in advance by March 24, 2010. There will be no onsite registration. We encourage attendees to register for the workshop electronically at: https://www.fda.gov/ Food/NewsEvents/Workshops MeetingsConferences/ucm201102.htm. If you need special accommodations due to disability, please contact Juanita PO 00000 Frm 00084 Fmt 4703 Sfmt 4703 Yates (see Contact Person) by March 24, 2010. The Federal Government and the food industry are pursuing major new efforts to reduce foodborne illness that include science-based preventive controls in food production and processing. As recommended by the President’s Food Safety Working Group (Ref. 1), one element of the Federal Government’s food safety initiatives includes regularly assessing performance metrics for measuring progress in reducing foodborne illness. FDA, the Centers for Disease Control and Prevention (CDC), and the U.S. Department of Agriculture’s (USDA) Food Safety and Inspection Service (FSIS) are collaborating to address the methodologic and data challenges involved in the development of feasible and effective food safety metrics. The agencies will engage the food safety expert and stakeholder communities to discuss this subject through a series of public workshops. SUPPLEMENTARY INFORMATION: I. Background FDA and FSIS base decisions about policies and other interventions related to food safety, in part, on CDC’s analyses of data on foodborne illness. These analyses are powerful tools for assessing the safety of food, which, in turn, reflects the effectiveness of Government and industry policies and interventions. The President’s Food Safety Working Group has noted the importance of assessing metrics (Ref. 1). Through its epidemiologic and laboratory data collection and analysis, CDC generates various types of measures and estimates of foodborne illness, via a number of mechanisms, which serve different purposes. For example, the Foodborne Diseases Active Surveillance Network (FoodNet) collects data on laboratory-confirmed cases of nine foodborne illnesses caused by bacteria and parasites commonly associated with foodborne human illness (e.g., Salmonella and Escherichia coli O157:H7). The cases are reported to CDC by State health authorities in 10 States representing 15 percent of the U.S. population (i.e., all of Connecticut, Georgia, Maryland, Minnesota, New Mexico, Oregon, and Tennessee and selected counties in California, Colorado, and New York). Based on the FoodNet data, CDC writes an annual report on the incidence and trends of laboratory-confirmed cases of these nine illnesses. The FoodNet also conducts special studies to determine risk factors for acquiring those illnesses. E:\FR\FM\01MRN1.SGM 01MRN1

Agencies

[Federal Register Volume 75, Number 39 (Monday, March 1, 2010)]
[Notices]
[Pages 9231-9232]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-4184]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Cancer Institute Special Emphasis Panel,

[[Page 9232]]

March 10, 2010, 8 a.m. to March 11, 2010, 6 p.m., Bethesda Marriott, 
5151 Pooks Hill Road, Bethesda, MD 20814 which was published in the 
Federal Register on February 1, 2010, 75 FR 5093.
    This FRN amends the dates of the meeting to May 10-11, 2010. The 
meeting is closed to the public.

    Dated: February 24, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-4184 Filed 2-26-10; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.